Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.23
Delayed Data
As of Dec 02
 -0.27 / -6.00%
Today’s Change
2.94
Today|||52-Week Range
20.48
-73.90%
Year-to-Date
No recent news for Y-mAbs Therapeutics Inc.

Today’s Trading

Previous close4.50
Today’s open4.21
Day’s range4.07 - 4.51
Volume52,339
Average volume (3 months)518,258
Market cap$184.5M
Data as of 3:59pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)+56.97%
Earnings growth (this year)-104.34%
Earnings growth (next 5 years)-88.68%
Revenue growth (last year)+68.18%
P/E ratioNM
Price/Sales20.06
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
ATXSAstria Therapeutics ...-0.19-1.73%
SVRASavara Inc+0.03+1.92%
----
GNFTGenfit SA+0.07+1.89%
Data as of 3:59pm ET, 12/02/2022

Financials

Next reporting dateFebruary 23, 2023
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$34.9M
Annual profit (last year)-$55.3M
Net profit margin-158.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts